Breast cancer
Results
Phase 3
This trial looked at a vaccine called Neuvax for breast cancer that has receptors for the HER2 protein and has spread to the .
Recruitment start: 1 November 2012
Recruitment end: 13 March 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mary O'Brien
Experimental Cancer Medicine Centre (ECMC)
Galena Biopharma
NIHR Clinical Research Network: Cancer
Last reviewed: 26 April 2021
CRUK internal database number: 10450
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
